Related Experiment Video
Updated: Jul 15, 2026
10:49
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
The global problem of early deaths in acute promyelocytic leukemia: A strategy to decrease induction mortality in the
1Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA.
Blood Reviews
|October 17, 2017
Summary
Acute promyelocytic leukemia (APL) has high early death rates, but this can be reduced. Implementing standardized guidelines and expert support significantly improves survival for this curable leukemia.
Area of Science:
- Hematology
- Oncology
- Leukemia Research
Background:
- Acute promyelocytic leukemia (APL) is a severe condition often presenting with cytopenias and disseminated intravascular coagulation (DIC).
- While effective treatments like all-trans retinoic acid (ATRA) and arsenic trioxide (ATO) exist, a significant challenge remains with high induction mortality rates (around 30%).
- Awareness of these early death (ED) rates is not universal among general hematologists and oncologists.
Purpose of the Study:
- To investigate strategies for reducing early deaths (ED) in acute promyelocytic leukemia (APL) induction.
- To highlight the effectiveness of standardized guidelines and expert consultation in improving population-wide survival rates for APL.
- To advocate for broader implementation of educational initiatives and expert support systems for treating oncologists.
Main Methods:
- Review of experience in reducing ED in academic and community centers over seven years.
- Analysis of population-wide prospective trials in Brazil and Georgia/South Carolina, USA, focusing on standardized guidelines and consultative support.
- Assessment of the impact of these interventions on early death rates in APL induction.
Main Results:
- Standardized treatment guidelines coupled with expert consultative support demonstrated effectiveness in reducing ED rates in APL induction.
- Prospective trials in Brazil and Georgia/South Carolina showed improvements in ED rates through implemented strategies.
- The approach of combining simplified guidelines with expert advice proved effective in experienced centers and population-wide trials.
Conclusions:
- Early death in APL is a significant and largely preventable problem.
- Implementing simplified treatment guidelines and providing expert consultative support during induction can substantially improve population-wide survival in APL.
- Aggressive education for oncologists and encouragement to seek expert advice are crucial for reducing induction mortality in APL.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...